Aptorum Group Ltd Class A (APM)

Aptorum Group Ltd Class A (APM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Jul 27, 2026: market cap $570,062; returns 1 week -4.8%.

Aptorum Group Limited (NASDAQ: APM) is a clinical-stage biopharmaceutical company primarily focused on the discovery, development, and commercialization of therapeutic assets for diseases with significant unmet medical needs, particularly within oncology, including orphan oncology indications, and infectious diseases.

APM financial model: income statement, cash flow and balance sheet